Biomarin Pharmaceutical reported $-53219000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Acorda Therapeutics ACOR:US $ -23.01M 7.32M
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amgen AMGN:US $ 2378M 1550M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
Bayer BAYN:GR 530M 2.81B
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Gilead Sciences GILD:US $ 3842M 1596M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Insmed INSM:US $ -103617000 2.64M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
IONIS PHARMACEUT IONS:US $ -86M 4.4M
Moderna Inc MRNA:US 3.56B 496M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Ptc Therapeutics PTCT:US $ -93.08M 5.42M
Puma Biotechnology PBYI:US $ -41.6M 39.87M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sangamo Biosciences SGMO:US $ -48.44M 0.26M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Seattle Genetics SGEN:US $ -297.96M 208.36M
Ultragenyx Pharmaceutical RARE:US $ -89.83M 7.05M
United Therapeutics UTHR:US $ 228.7M 8.8M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M
YTE INCY:US $ 235.41M 94.57M